AB062. Investigating miR-21 as a non-invasive prognostic biomarker in glioma patients
Our findings validate the utility of miR-21 as a prognostic serum biomarker to help diagnose and assess treatment response in advancing glioma grades, within our population.
Authors
- Sufiyan Sufiyan (ORCID: https://orcid.org/0000-0002-0208-0206)
- Sahar Ilyas
- Nouman Mughal (ORCID: https://orcid.org/0000-0002-3298-3959)
- Altaf Ali Laghari
- Hamza Bajwa
- Syed Ather Enam (ORCID: https://orcid.org/0000-0003-2194-0723)
- Wajiha Amin (ORCID: https://orcid.org/0009-0005-4543-2258)
- Siraj Uddin (ORCID: https://orcid.org/0000-0003-4511-8697)
- Sana Naeem
Institutions
- Aga Khan University Hospital (PK)
Publication Details
- Journal
- Chinese Clinical Oncology
- Published
- 2024-08-01
- DOI
- https://doi.org/10.21037/cco-24-ab062
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00